Evidence map›Paper›PMID 37314619›Full record

ArticleMetabolic brain disease2023

Neuroprotective effects of vitamin B1 on memory impairment and suppression of pro-inflammatory cytokines in traumatic brain injury.

Mansoor Husn, Zarnosh Amin, Yousaf Ali, Lubna Kanwal, Kehkashan Sabir, Shahid Ali Shah, Syed Farhan Shah

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Food science & nutrition · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mansoor HusnDepartment of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Pakistan.ORCID http://orcid.org/0000-0003-2618-3004
Zarnosh AminDepartment of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Pakistan.ORCID http://orcid.org/0009-0006-9690-0979
Yousaf AliDepartment of Chemistry, Federal Government College Batkhela, FGEIs (C/G), Khyber Pakhtunkhwa, Pakistan. usaf_pk@yahoo.com.ORCID http://orcid.org/0000-0002-7877-8918
Lubna KanwalAtta Ur Rahman School of Applied Biosciences (ASAB), National University of Science and Technology, Islamabad, 0000-0003-2618-3004, Pakistan.ORCID http://orcid.org/0009-0000-4637-3724
Kehkashan SabirDepartment of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Pakistan.ORCID http://orcid.org/0009-0009-2887-3069
Shahid Ali ShahDepartment of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Pakistan.ORCID http://orcid.org/0000-0002-5341-646X
Syed Farhan ShahDepartment of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Pakistan.ORCID https://orcid.org/0009-0005-7859-793X
Sarhad University of Science and Information Technology · PKGovernment of Khyber Pakhtunkhwa · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic Brain Injury (TBI) remains one of the prevailing disorders that affect millions of people around the globe. There is a cascade of secondary attributes attached to TBI including excitotoxicity, axonal degeneration, neuroinflammation, oxidative stress, and apoptosis. Neuroinflammation is caused due to the activation of microglia along with pro-inflammatory cytokines. The activation of microglia triggers TNF-α which sequentially results in the triggering and upregulation of NF-kB. The aim of the current research was to investigate vitamin B1's potential as neuroprotective agent against TBI-induced neuroinflammation arbitrated memory impairment together with pre- and post-synaptic dysfunction in an adult albino male mice model. TBI was induced using the weight-drop method which caused the microglial activation resulting in neuroinflammation along with synaptic dysfunction leading to the memory impairment of the adult mice. Vitamin B1 was administered for seven days via the intraperitoneal pathway. To analyze the memory impairment and efficacy of vitamin B1, Morris water maze and Y-maze tests were performed. The escape latency time and short-term memories of the experimental mice treated with vitamin B1 were significantly different from the reference mice. The western blot results showed that vitamin B1 has reduced neuroinflammation by downregulating proinflammatory cytokines (NFκ-B, TNF- α). Vitamin B1 also proved its worthiness as a convincing neuroprotective agent by reducing memory dysfunction and recovering the activities of pre- and post-synapse via upregulation of synaptophysin and Postsynaptic density protein 95 (PSD-95).

Indexed as

Brain Injuries, TraumaticNeuroprotective AgentsAnimalsCytokinesDisease Models, AnimalInflammationMemory DisordersMiceMice, Inbred C57BLMicrogliaNeuroinflammatory DiseasesNF-kappa BThiamineTumor Necrosis Factor-alphaCytokinesNeuroprotective AgentsNF-kappa BThiamineTumor Necrosis Factor-alphaNeuroinflammationNFκ-BPSD95Synaptophysin (SYP)TNF- αTraumatic brain InjuryVitamin B1Western blot

Identifiers

PMID37314619
OpenAlexW4380577455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.